bioAffinity Technologies (BIAF) vs NRC Health (NRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NRC Health is the larger company by market cap ($445.5 million vs $5.7 million), about 78.8 times the size. NRC Health pays a dividend yielding 2.98%, while bioAffinity Technologies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | NRC |
|---|---|---|
| Share price | $4.85 | $20.14 |
| Market cap | $5.65M | $445.49M |
| 1-day change | -14.08% | -1.37% |
| YTD return | — | +8.79% |
| 1-year return | — | +71.31% |
| 5-year return | — | -52.38% |
| P/E ratio (TTM) | — | 83.92 |
| Forward P/E | — | 19.18 |
| EPS (TTM) | $-109.35 | $0.24 |
| Dividend yield | 0.00% | 2.98% |
| Annual dividend | $0.00 | $0.60 |
| 52-week high | $80.70 | $23.68 |
| 52-week low | $4.56 | $11.01 |
| Distance from 52-week high | -94.00% | -14.95% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +29.10% |
| Average volume | 3.67M | 115.97K |
| Shares outstanding | 1.17M | 22.12M |
| Employees | 57 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRC Health is about 78.8 times larger than bioAffinity Technologies by market value ($445.49M vs $5.65M).
- NRC Health offers a meaningfully higher dividend yield (2.98% vs 0.00%).
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
BIAF vs NRC FAQ
Which is bigger, bioAffinity Technologies or NRC Health?
NRC Health (NRC) is larger, with a market capitalization of $445.49M compared with $5.65M for bioAffinity Technologies (BIAF).
Which pays a higher dividend, bioAffinity Technologies or NRC Health?
NRC Health pays a dividend yielding 2.98%, while bioAffinity Technologies does not currently pay a regular dividend.
Are bioAffinity Technologies and NRC Health in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.